December 21, 2012
Mallinckrodt Provides Additional Information on Dutch High-Flux Reactor
Mallinckrodt, the Pharmaceutical business of Covidien, has provided additional information regarding the delayed return to operation for the Dutch High-Flux Reactor (HFR). Mallinckrodt has been informed that the reactor will not restart in December.
For more information, please find the letter below.